<DOC>
	<DOCNO>NCT00362479</DOCNO>
	<brief_summary>This open-label , single treatment study . All subject receive 6 month oral contraceptive therapy DR-1021 . Study participant receive physical gynecological exam , include Pap smear . During study , participant require complete diary .</brief_summary>
	<brief_title>Open-Label Study Evaluate Safety Efficacy Low-Dose 28-Day Oral Contraceptive</brief_title>
	<detailed_description>The overall study duration patient approximately 8 month , include screening period approximately 4 week ; treatment period approximately six month ( six,28-day cycle ) ; follow-up visit approximately 4 week completion study drug .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Premenopausal Not pregnant breastfeed Sexually active risk pregnancy Any contraindication use oral contraceptive Pregnancy within last 3 month Smoking &gt; 10 cigarette per day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>pregnancy prevention</keyword>
	<keyword>oral contraceptive</keyword>
</DOC>